Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins

Details for Australian Patent Application No. 2005201826 (hide)

International Classifications

Event Publications

12 May 2005 Complete Application Filed

26 May 2005 Application Open to Public Inspection

Published as AU-B-2005201826

14 December 2006 Change of Name(s) of Applicant(s), Section 104

StressGen Biotechnologies Corp. The name of the applicant has been changed to Nventa Biopharmaceuticals Corporation

17 January 2008 Application Accepted

Published as AU-B-2005201826

15 May 2008 Standard Patent Sealed

13 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.